Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin discontinuation timing in late pregnancy for prevention of preeclampsia
IRCT20190208042655N4Phase 3Recruiting
- Sponsor
- Tehran University of Medical Sciences
- Start
- Apr 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of aspirin in preeclampsia (3 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Incidence of preeclampsia. Started Apr 2025; status: recruiting.
02
Drugs
aspirin
03
Conditions
preeclampsia
Beyond the preview
Go deeper on IRCT20190208042655N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190208042655N4.